Who
Gerald M. Lieberman
Director
Company insider
Files Form 4 as: Director, Teva Pharmaceutical Industries; Director, Entera Bio; Director, Forest Laboratories; President and COO, AllianceBernstein Holding L.P. Units; President and COO, Alliancebernstein L.P.
In numbers
- Trades disclosed
- 84
- Buys
- 5
- Sells
- 0
- Bought
- $98K
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 3 Feb 2006
- Last trade
- 5 Jun 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jun 2026filed 8 Jun 2026 | TEVA Teva Pharmaceutical IndustriesPharmaceuticals | SEC FORM 4 Code M | —14,492 | filing |
| 5 Jun 2026filed 8 Jun 2026 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —14,492 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —14,492 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | TEVA Teva Pharmaceutical IndustriesPharmaceuticals | SEC FORM 4 Code M | —14,492 | filing |
| 28 May 2026filed 1 Jun 2026 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —7,242 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —7,242 at $0.00 | filing |
| 1 Jan 2026filed 2 Jan 2026 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —38,294 at $0.00 | filing |
| 1 Jan 2026filed 2 Jan 2026 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —33,505 at $0.00 | filing |
| 1 Jan 2026filed 2 Jan 2026 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —33,505 at $0.00 | filing |
| 1 Jan 2026filed 2 Jan 2026 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —38,294 at $0.00 | filing |
| 6 Jun 2025filed 9 Jun 2025 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —9,632 at $0.00 | filing |
| 6 Jun 2025filed 9 Jun 2025 | TEVA Teva Pharmaceutical IndustriesPharmaceuticals | SEC FORM 4 Code M | —9,632 | filing |
| 5 Jun 2025filed 9 Jun 2025 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —14,492 at $0.00 | filing |
| 1 Apr 2025filed 3 Apr 2025 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —23,952 at $0.00 | filing |
| 1 Apr 2025filed 3 Apr 2025 | ENTX Entera BioBiotechnology | SEC FORM 4 Code M | $24K23,952 at $1.00 | filing |
| 15 Jan 2025filed 17 Jan 2025 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —28,509 at $0.00 | filing |
| 15 Jan 2025filed 17 Jan 2025 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —10,717 at $0.00 | filing |
| 2 Oct 2024filed 4 Oct 2024 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —11,269 at $0.00 | filing |
| 27 Aug 2024filed 29 Aug 2024 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —27,261 at $0.00 | filing |
| 15 Jun 2024filed 17 Jun 2024 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —21,108 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.